Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-09-11

FDA Approved: ILOPERIDONE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for iloperidone from Mylan Pharmaceuticals Inc., authorizing a generic version of iloperidone to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Iloperidone (iloperidone)

Snippet

SUPPL AP for ILOPERIDONE (ILOPERIDONE)